dc.contributor.author | Bangash, MN | en_US |
dc.contributor.author | Patel, NSA | en_US |
dc.contributor.author | Benetti, E | en_US |
dc.contributor.author | Collino, M | en_US |
dc.contributor.author | Hinds, CJ | en_US |
dc.contributor.author | Thiemermann, C | en_US |
dc.contributor.author | Pearse, RM | en_US |
dc.date.accessioned | 2013-09-13T08:46:51Z | |
dc.date.available | 2013-03-18 | en_US |
dc.date.issued | 2013 | en_US |
dc.identifier.issn | 1466-609X | en_US |
dc.identifier.other | ARTN R57 | en_US |
dc.identifier.other | ARTN R57 | en_US |
dc.identifier.other | ARTN R57 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/4380 | |
dc.description | This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
dc.relation.ispartof | CRITICAL CARE | en_US |
dc.rights | © 2013 Bangash et al.; licensee BioMed Central Ltd. | |
dc.title | Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flow | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1186/cc12585 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000327887300022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 2 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 17 | en_US |